A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in… read more.
A nationwide assessment of Obstetrics and Gynecology residency programs reveals the need for more training in how to provide the best care for women going through menopause, according… read more.
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progression-free survival rate of 24% and an overall survival rate of 83%…. read more.
A new study suggests that increasing rates of induction of labour (IOL) of pregnant women and people in the UK, without considering the accompanying, real-world impact on staffing workloads and… read more.
The COVID-19 pandemic exacerbated fear of childbirth among pregnant people in the U.S., according to a new Dartmouth study. The researchers were particularly interested in understanding, from a… read more.
Eight low-cost and easily implementable proven interventions for pregnant women in 81 low- and middle-income countries (LMICs) could prevent an estimated 566,000 stillbirths and 5.2 million babies a… read more.
Gestational diabetes (GDM) and overweight during pregnancy are associated with increased risk for type 2 diabetes. Although postpartum weight loss can reduce diabetes risk, effective interventions are lacking… read more.
Results from a trial published in the International Journal of Gynecology & Obstetrics support the benefit of 3D virtual reality lessons to improve medical students’ knowledge and understanding of complex… read more.
Treating babies with antibiotics in the first week of life is linked with a decrease in healthy bacteria necessary amongst others to digest milk and an increase in… read more.
Treatment for high blood pressure during pregnancy appears safe for many women and may reduce maternal risk for severe hypertension without increasing fetal and neonatal risks, according to… read more.
In the state of Washington, a planned home birth with a licensed midwife is just as safe as a birth at a licensed birth centre. Researchers from the… read more.
Lupin Pharmaceuticals announced that the FDA has approved the company’s supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis… read more.